Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Alvarez

Showing results (571-580 of 644) with videos related to

Pageof 65
Sort By:
Gynecologic Oncology|August 7, 2004
Infectivity enhanced adenoviral-mediated mda-7/IL-24 gene therapy for ovarian carcinomaCharles A Leath, Manjula Kataram, Pradeep Bhagavatula, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2012
A phase I clinical trial of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in patients with recurrent gynecologic cancerKenneth H Kim, Igor Dmitriev, Janis P O'Malley, et al.
Cancers|March 11, 2023
Phenotypic Plasticity in Circulating Tumor Cells Is Associated with Poor Response to Therapy in Metastatic Breast Cancer PatientsEvan N Cohen, Gitanjali Jayachandran, Hui Gao, et al.
Cancer Research|March 13, 2002
Treatment of ovarian cancer with a tropism modified oncolytic adenovirusGerd J Bauerschmitz, John T Lam, Anna Kanerva, et al.
The Journal of Gene Medicine|October 20, 2004
Inter-patient variation in efficacy of five oncolytic adenovirus candidates for ovarian cancer therapyJohn T Lam, Anna Kanerva, Gerd J Bauerschmitz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 8, 2001
An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expressionA Hemminki, N Belousova, K R Zinn, et al.
Molecular Imaging|September 25, 2014
Monitoring of biodistribution and persistence of conditionally replicative adenovirus in a murine model of ovarian cancer using capsid-incorporated mCherry and expression of human somatostatin receptor subtype 2 geneIgor P Dmitriev, Elena A Kashentseva, Kenneth H Kim, et al.
International Journal of Oncology|May 24, 2008
Development of an optimized conditionally replicative adenoviral agent for ovarian cancerZeng B Zhu, Baogen Lu, Miey Park, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2003
Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirusAnna Kanerva, Kurt R Zinn, Tandra R Chaudhuri, et al.
Cell Death & Disease|December 7, 2013
A candidate anti-HIV reservoir compound, auranofin, exerts a selective 'anti-memory' effect by exploiting the baseline oxidative status of lymphocytesB Chirullo, R Sgarbanti, D Limongi, et al.
Pageof 65

Showing results (571-580 of 644) with videos related to

Sort By:
Pageof 65
Gynecologic Oncology|August 7, 2004
Infectivity enhanced adenoviral-mediated mda-7/IL-24 gene therapy for ovarian carcinomaCharles A Leath, Manjula Kataram, Pradeep Bhagavatula, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2012
A phase I clinical trial of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in patients with recurrent gynecologic cancerKenneth H Kim, Igor Dmitriev, Janis P O'Malley, et al.
Cancers|March 11, 2023
Phenotypic Plasticity in Circulating Tumor Cells Is Associated with Poor Response to Therapy in Metastatic Breast Cancer PatientsEvan N Cohen, Gitanjali Jayachandran, Hui Gao, et al.
Cancer Research|March 13, 2002
Treatment of ovarian cancer with a tropism modified oncolytic adenovirusGerd J Bauerschmitz, John T Lam, Anna Kanerva, et al.
The Journal of Gene Medicine|October 20, 2004
Inter-patient variation in efficacy of five oncolytic adenovirus candidates for ovarian cancer therapyJohn T Lam, Anna Kanerva, Gerd J Bauerschmitz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 8, 2001
An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expressionA Hemminki, N Belousova, K R Zinn, et al.
Molecular Imaging|September 25, 2014
Monitoring of biodistribution and persistence of conditionally replicative adenovirus in a murine model of ovarian cancer using capsid-incorporated mCherry and expression of human somatostatin receptor subtype 2 geneIgor P Dmitriev, Elena A Kashentseva, Kenneth H Kim, et al.
International Journal of Oncology|May 24, 2008
Development of an optimized conditionally replicative adenoviral agent for ovarian cancerZeng B Zhu, Baogen Lu, Miey Park, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2003
Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirusAnna Kanerva, Kurt R Zinn, Tandra R Chaudhuri, et al.
Cell Death & Disease|December 7, 2013
A candidate anti-HIV reservoir compound, auranofin, exerts a selective 'anti-memory' effect by exploiting the baseline oxidative status of lymphocytesB Chirullo, R Sgarbanti, D Limongi, et al.
Pageof 65